Home | Contact
     ISSN 2149-2042
     e-ISSN 2149-4606
 
 
 
Volume : 36 Issue : 3 Year : 2021



Current Issue Archive Popular Articles Ahead of Print




Index














Membership




Applications



 
HBsAg seroconversion with pegylated interferon treatment for chronic hepatitis B [Medeniyet Med J]
Medeniyet Med J. 2007; 22(4): 156-157

HBsAg seroconversion with pegylated interferon treatment for chronic hepatitis B

Feruze Yılmaz Enç, Canan Yeşiloğlu
Göztepe Training and Research Hospital, Gastroenterology, Istanbul

Each year HBsAg seroconversion appears spontenously between the range of 1-2 percent and also antiHBs appears in 1/3 of these cases. HBsAg seroconversion is % 4 for the treatment with convensional interferon and this rate is also similar for the treatment with pegylated interferon. Here we present a patient with chronic hepatitis B who treated with pegylated interferon, had seroconversion of HBsAg.

Keywords: Chronic hepatit B, treatment with peginterferon, anti HBs apperance


Kronik hepatit B’de peginterferon tedavisi

Feruze Yılmaz Enç, Canan Yeşiloğlu
Göztepe Eğitim Araştırma Hastanesi, Gastroenteroloji Kliniği, İstanbul

Anahtar Kelimeler: Kronik hepatit B, peginterferon tedavisi, anti HBs pozitifleşmesi


Feruze Yılmaz Enç, Canan Yeşiloğlu. HBsAg seroconversion with pegylated interferon treatment for chronic hepatitis B. Medeniyet Med J. 2007; 22(4): 156-157

Corresponding Author: Feruze Yılmaz Enç, Türkiye


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar





 

  Copyright © 2019 MEDJ All Rights Reserved